Director
Takeda
Cambridge, Massachusetts
Haiqing Wang is the Director of Oncology DMPK group in Takeda at Cambridge. Before she joined Takeda in 2018, she had worked in the Metabolism and Pharmacokinetics (MAP) group at Bristol Myers Squibb in Princetin for 10 years and also worked briefly at Genentech in South San Francisco. She received her Ph.D. in college of Pharmacy in University of Minnesota. Her main research interest is model-based PK/PD/efficacy analysis to drive preclinical to clinical dose and efficacy translation
Disclosure information not submitted.
Monday, October 17, 2022
3:00 PM – 4:00 PM ET
Tuesday, October 18, 2022
10:00 AM – 10:30 AM ET